US FDA warns Abbott Labs over heart device problems


The U.S. Food and Drug Administration issued a warning letter to Abbott Laboratories, citing manufacturing flaws with a range of cardiovascular devices acquired with its purchase of St. Jude Medical in January for $25 billion. The letter, dated April 12 and made public, sent Abbott’s shares down 2 percent to $42.61. The FDA, which said the company failed to disclose at least one death associated with one of the devices, said an inspection of the company’s facility in Sylmar, California, raised.

US FDA warns Abbott Labs over heart device problems

Read more at Medical Dialogues: US FDA warns Abbott Labs over heart device problems http://business.medicaldialogues.in/us-fda-warns-abbott-labs-over-heart-device-problems/

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s